Clinical Trial Update: Comparison Of Different Doses Of Intrathecal Neostigmine In Prevention Of Post-Dural Puncture Headache [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial evaluating different doses of intrathecal neostigmine to prevent post-dural puncture headache.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache

Drugs mentioned

• Neostigmine (neostigmine)

Snippet

Sponsor: Cairo University | Conditions: Headache | Phase 2, Phase 3 | Status: UNKNOWN